Cory Berkland

Affiliations: 
Bioengineering University of Kansas, Lawrence, KS, United States 
Area:
Biomedical Engineering, Pharmaceutical Chemistry, Nanotechnology
Google:
"Cory Berkland"

Parents

Sign in to add mentor
Daniel W. Pack grad student 1999-2004 UIUC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Apley KD, Griffith AS, Downes GM, et al. (2023) CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation. Bioconjugate Chemistry
Johnson SN, Brucks SD, Apley KD, et al. (2023) Multivalent Scaffolds to Promote B cell Tolerance. Molecular Pharmaceutics
Chakravarti AR, Groer CE, Gong H, et al. (2023) Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors. Molecular Pharmaceutics
Huang A, Kurhade SE, Ross P, et al. (2022) Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. Acs Pharmacology & Translational Science. 5: 1062-1069
Apley KD, Laflin AD, Johnson SN, et al. (2021) Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation. Industrial & Engineering Chemistry Research. 60: 16839-16853
Apley KD, Griffin JD, Johnson SN, et al. (2020) Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B Cells. Journal of Visualized Experiments : Jove
Groer C, Zhang T, Lu R, et al. (2020) Intratumoral cancer chemotherapy with a carrier-based immunogenic cell death eliciting platinum (IV) agent. Molecular Pharmaceutics
Leon MA, Firdessa-Fite R, Ruffalo JK, et al. (2019) Soluble Antigen Arrays Displaying Mimotopes Direct the Response of Diabetogenic T Cells. Acs Chemical Biology
Lu R, Groer C, Kleindl PA, et al. (2019) Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Journal of Controlled Release : Official Journal of the Controlled Release Society
Pickens CJ, Christopher MA, Leon MA, et al. (2019) Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders. Molecular Pharmaceutics
See more...